[Hepatic encephalopathy].
This is a review of basic concepts on the etiopathogeny and treatment of hepatic encephalopathy focusing in more detail on the role of amino acids and neurotransmitters in precipitating the neurological picture.
D000596:Amino Acids / Q000097:blood / Q000627:therapeutic use; D000641:Ammonia / Q000097:blood; D001971:Bromocriptine / Q000627:therapeutic use; D005232:Fatty Acids, Volatile / Q000097:blood; D006501:Hepatic Encephalopathy / Q000209:etiology / Q000473:pathology / Q000628:therapy; D006801:Humans; D007081:Ileostomy; D007792:Lactulose / Q000627:therapeutic use; D008795:Metronidazole / Q000627:therapeutic use; D018377:Neurotransmitter Agents / Q000097:blood
D000596:Amino Acids; D005232:Fatty Acids, Volatile; D018377:Neurotransmitter Agents; D008795:Metronidazole; D001971:Bromocriptine; D007792:Lactulose; D000641:Ammonia
Encefalopatia hepática.